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  ABSTRACT 
The most effective method of sustainable weight loss in obese patients is bariatric 
surgery. However, micronutrient deficiencies that can result after bariatric surgery 
can cause health problems that may outweigh its benefits. Micronutrient 
deficiencies are most common in patients who undergo Roux-en-Y gastric bypass 
or biliopancreatic diversion with or without duodenal switch. The majority of 
vitamin B12 and folate deficiencies studies showed significant prevalence rates in 
their patient populations. Most concluded that routine oral B12 supplementation 
was ineffective at resolving deficiency; very high oral doses (> 350 µg) or 
intramuscular injections of crystalline B12 were typically required. Studies of iron 
deficiency after bariatric surgery found high prevalence rates due to inadequate 
oral supplementation, which can lead to the need for parenteral supplementation. 
Calcium and vitamin D deficiency studies also showed high prevalence rates of 
deficiency, which is important to address as deficiency can result in metabolic 
bone disease. Overall, the need for lifelong supplementation and follow up, early 
detection of deficiencies, patient education, and more aggressive supplementation 
regiments were emphasized to increase quality of life in bariatric surgery patients. 
Future research in bariatric surgery studies should include long-term health 
outcomes, patient education on required supplementation, and more aggressive 
supplementation regimens.   
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 Introduction 
Throughout the past several decades, prevalence of overweight and obesity in the United 
States has steadily increased. National Health and Nutrition Examination Survey (NHANES) 
data from 2007-2008 show an age-adjusted combined prevalence rate of 68% overall in both 
men and women in the U.S. (Flegal, Carroll, Ogden, & Curtin, 2010). Overweight is defined as a 
body mass index (BMI) of 25.0-29.9, and obese is classified as a BMI >30.0. Over one-third of 
the U.S. population is obese, and approximately 15 million Americans have a BMI >40, labeled 
as morbid obesity (Nagle, 2010). Consequences of overweight and obesity manifest as increased 
risk for developing chronic health conditions such as coronary heart disease, type 2 diabetes 
mellitus, hypertension, dyslipidemia, osteoarthritis, some cancers, and other chronic diseases, 
resulting in important public health concerns (National Heart, Lung and Blood Institute 
[NHLBI], 1998). Medical costs attributed to obesity are as high as $147 billion annually; obese 
persons spent on average 42% more on health care than persons of normal weight (Centers for 
Disease Control and Prevention [CDC], 2009). 
           The most effective long-term solution for the morbidly obese is bariatric surgery, which 
has been shown to achieve sustainable and significant weight loss, improve chronic 
comorbidities, and reduce risk of mortality (Toh, Zarshenas, & Jorgensen, 2009). Bariatric 
surgery patients achieve weight loss of 30% to 70% of excess body weight, compared to 5% to 
10% with non-surgical weight loss approaches (Kushner & Neff, 2010). Bariatric surgeries are 
growing more popular, as approximately 220,000 bariatric procedures were performed in the 
U.S. in 2008; however, only 1% of eligible persons undergo the procedure. Eligibility requires a 
BMI of >40 or >35 with an obesity-related disease (American Society for Metabolic and 
Bariatric Surgery [ASBS]). These procedures result in gastrointestinal anatomy and physiologic 
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changes; altered diet quality and quantity; malabsorption; and can lead to macronutrient and 
micronutrient deficiencies (Toh et al., 2009). Overall incidence of developing complications after 
the surgery is low; the most common major complications being gastrointestinal leaks, 
pulmonary embolus, anastomotic stricture, esophageal ulcer, and hernia (Malinowski, 2006). The 
purpose of this review is to provide an overview of common bariatric procedures and the 
micronutrient deficiencies that can result.  
Bariatric Surgery 
 Several different bariatric surgeries are performed, each with their own unique 
procedures and complications. Figure 1 below is a basic diagram of how the stomach and small 
intestine are altered in each procedure.  
Figure 1. Four surgical procedures of bariatric 
surgery (Pories, 2009). 
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Gastric Bypass 
 Roux-en-Y gastric bypass. The standard Roux-en-Y gastric bypass (RYGBP) procedure, 
the most common bariatric surgery performed in the United States, involves connecting the 
jejunum to a small pouch, created at the proximal portion of the stomach, with a capacity of 15-
30 mL (Nelms, Sucher, & Long, 2007; ASBS, 2005; Federle & Blachar, 2002). The amount of 
small intestine bypassed in the standard procedure does not cause macronutrient malabsoprtion. 
However, the bypassed portion of the small intestine is where most iron and calcium absorption 
takes place, which can result in long-term complications such as anemia and osteoporosis 
(ASBS, 2005). In the distal RYGBP procedure, the surgeon modifies the standard RYGBP to 
cause both volume restriction and macronutrient malabsorption. Weight loss after the distal 
RYGBP is greater than the standard procedure but results in more severe nutritional deficiencies 
(ASBS, 2005). Cholelithiasis, formation of cholesterol stones in the gallbladder, is a common 
complication of RYGBP, due to the rapid weight loss, with reported incidence rates of 50%. Use 
of ursodiol for six months after RYGBP has been effective in reducing gallstone formation. 
Some surgeons choose to prophylactically remove the gallbladder at the time of surgery 
(Malinowski, 2006). 
             The laparoscopic RYGBP procedure is usually performed through five to six small 
abdominal incisions of 0.5 to 2.0 cm in length, whereas the open surgical procedure requires 
larger incisions and abdominal wall retractors for exposure (ASBS, 2005). Most complications 
are minor, usually consisting of incision drainage, urinary tract infection, nausea, or painful 
abdominal wall muscle spasms. Major complications occur in less than 1% of patients, and 
include serious wound infection, intra-abdominal bleeding, infections within the abdomen, and 
hernias (Duke University Health System, 2007). Laparoscopic RYGBP results in less blood loss, 
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shorter hospital stays, reduced postoperative pain, less pulmonary complications, faster recovery, 
and fewer incisional hernias and infections. The open surgery procedure is reserved for patients 
with an extremely high BMI, multiple previous upper abdominal surgeries, and patients who 
have previously undergone bariatric surgery (ASBS, 2005).  
           Biliopancreatic diversion. The biliopancreatic diversion (BPD) procedure works through 
significant malabsorption of nutrients by removing approximately 70% of the stomach and 
creating a much shorter anastomosis (connection of two hollow organs) into the small intestine 
than the RYGBP procedure. The post-operation stomach produces significantly less gastric acid. 
Stomach volume is much greater than the RYGBP pouch, which allows for patients to eat larger 
volumes of food before experiencing satiety (ASBS, 2005). The amount of excess weight shed 
by BPD patients has been reported around 70% with weight loss persisting in some patients for 
up to 18 years. Life-long medical follow-up is required due to the highly malabsorptive nature of 
the procedure (ASBS, 2005).  
                Duodenal switch. Duodenal switch (DS) is a modification of BPD in which the 
stomach is fashioned into a small tube, preserving the pylorus. Then a lengthy portion of the 
duodenum is rerouted to create two separate pathways and one common channel. The digestive 
loop, the shorter of the two pathways, moves chyme (partially digested food) from the stomach 
to the common channel. The longer biliopancreatic loop carries bile from the liver to the 
common channel. The common channel consists of 75 to 150 cm of the small intestine, in which 
the chyme mixes with the bile before emptying into the colon. This reduces the amount of time 
the body has to gain energy from the chyme in the small intestine and limits fat absorption. The 
duodenum is tolerant of gastric acid, and is much less prone to ulceration than the ileum and 
jejunum (Baltasar et al., 2001; ASBS, 2005). The BPD/DS procedure also prevents dumping 
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syndrome, a condition that involves rapid gastric emptying into the small intestine before food is 
digested, resulting in diarrhea, bloating, and other uncomfortable symptoms due to hyperosmolar 
food (Baltasar et al., 2001; Nelms et al., 2007; ASBS, 2005).  However, a skilled surgeon is 
necessary due to the location of several large blood vessels and the major bile duct next to the 
duodenum. Injury to these structures can be life-threatening (ASBS, 2005).  
Restrictive Procedures 
           Vertical-banded gastroplasty. Vertical-banded gastroplasty (VGB) (not shown in Figure 
1) combines the creation of a pouch based on the lesser curvature of the stomach and a 
polypropylene mesh band around the outlet of the pouch (ASBS, 2005). Lack of anastomosis 
results in a lower risk of contracting infection, and also features low risk of micronutrient 
deficiencies and mortality (ASBS, 2005). The procedure’s popularity has decreased due to high 
risk of weight regain and exacerbation of severe heartburn (ASBS, 2005).  
          Sleeve gastrectomy. Sleeve gastrectomy (SG) is a restrictive procedure in which 
approximately 60% of the stomach is removed laparoscopically so that the stomach takes the 
shape of a tube, or “sleeve.” This procedure is typically reserved for superobese patients (BMI 
>50) or high-risk patients, in which performing a malabsorptive or more extreme procedure in 
the beginning may cause a higher risk of complications. Sleeve gastrectomy is usually performed 
with the intention of following up with a duodenal switch or Roux-en-Y procedure at a later 
time, if the patient does not lose enough weight by SG alone (Columbia University Center for 
Metabolic and Weight Loss Surgery [CUCMWLS]). The combined surgery approach has 
decreased risk of bariatric surgery for specific groups of patients, even compared to the sum of 
the risks of the two surgeries. Most patients undergoing sleeve gastrectomy alone can expect to 
lose 30% to 50% of their excess weight, over a 6- to 12-month period (CUCMWLS). However, 
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it is also used as a one-stage restrictive long-term procedure and has also been performed on 
patients who underwent BPD or BPD-DS and failed to achieve adequate weight loss (Frezza, 
2007).  
 Adjustable gastric banding. Laparoscopic adjustable gastric banding (AGB) is the least 
invasive surgical approach to treat obesity. Instead of cutting the stomach and/or intestine, the 
gastric band divides the stomach into a small upper pouch above the band and a larger pouch 
below the band. This restricts the amount of food intake at one given time similar to the 
restrictive procedures, and no malabsorption is involved (Brown, Korin, Burton & O’Brien, 
2009). A unique feature of AGB is that the stoma between the two parts of the stomach can be 
adjusted after the surgery by altering the amount of saline in the band and is a normal part of 
follow-up. Because the band can be later adjusted and/or removed and the stomach anatomy is 
not permanently altered, it is a less drastic option for patients who might not consider other more 
invasive procedures as viable treatment options. Perioperative death or complication risks are 
very low, at 0.05% and 2.6%, respectively (Brown, Korin, Burton & O’Brien, 2009). Hospital 
stays are usually shorter after AGB. Estimated weight loss is approximately 40% to 60% of 
excess body weight over a two-year span (CUCMWLS). Late complications are usually related 
to the band becoming displaced, which tend to arise from the patient eating too much food too 
quickly against a band that is too tight (Brown et al., 2009). Gastric bypass is usually preferred to 
AGB in the most severely obese patients (Coupaye et al., 2009).  
Micronutrient Deficiencies Resulting from Bariatric Surgery 
 The nutritional and metabolic complications from bariatric surgery can significantly 
detract from weight loss benefits. In most cases, these complications can be predicted, prevented, 
and treated. They are to a large degree directly related to the surgically-induced anatomical 
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changes in the gastrointestinal tract, as well as patient non-compliance with prescribed 
nutritional supplementation, clinical follow-up visits, and appropriate dietary modifications 
(Malinowski, 2006). The extent to which nutrients are rendered unavailable to the body is 
dependent on the type of procedure. Common micronutrient deficiencies that occur in RYGBP 
and BPD patients include severe malnutrition; vitamin B12, folate, iron, calcium, and fat-soluble 
vitamin deficiencies (Malinowski, 2006). Figure 2 depicts where macro and micronutrients are 
absorbed in the gastrointestinal tract.  
                                           
           Figure 2. Absorption sites of the gastrointestinal tract (Bloomberg et al, 2005).	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Vitamin B12 and Folate Deficiencies 
 Pathophysiology. Folate is most efficiently absorbed in the jejunum, however, if folate is 
not continuously supplemented, malabsorption and short bowel problems that result from gastric 
bypass can quickly result in deficiency (Gropper, Smith & Groff, 2009; Malinowski, 2006). 
Under normal conditions, vitamin B12 is released from animal protein sources by hydrochloric 
acid and pepsin in the stomach. R-binder proteins, secreted by saliva and gastric juices then 
attach to B12, are released a second time by pancreatic enzymes in the duodenum. The B12 
molecule then binds to intrinsic factor to form a proteolytic-resistant complex that remains intact 
until it adheres to specific receptors in the distal ileum prior to absorption (Rhode et al., 1995). 
After gastric bypass, the pouch does not produce sufficient hydrochloric acid or possibly pepsin 
to cleave B12 from ingested protein. Bypass of the duodenum, decreased contact time with the 
terminal ileum, and intolerance of red meats after bariatric surgery contribute to decreased B12 
bioavailability (Rhode et al., 1995; Malinowski, 2006).  
             Deficiency of folate and/or B12 results in megaloblastic macrocytic anemia, a condition 
in which proerythroblasts and erythrocytes fail to mature and are abnormally large due to 
dysfunctional DNA synthesis (Gropper et al., 2009). Signs and symptoms are typically of 
hematologic and neurologic origin; signs include skin pallor, fatigue, palpitations, tingling and 
numbness in extremities, loss of concentration, disorientation, and dementia (Gropper et al., 
2009).  
 Diagnosis of deficiency. Folate status is most often assessed by measuring plasma, serum, 
or erythrocyte folate concentrations (Gropper et al., 2009). The primary Schilling test measures 
absorption of B12 via oral ingestion then intramuscular injection of B12. Analysis of a urine 
sample determines if absorption is sufficient (ADAM Medical Encyclopedia, 2010). Gastric 
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bypass patients usually show ability to absorb crystalline B12 by the primary Schilling test 
(Rhode et al., 1995). Folate deficiency usually consists of a serum level <6.8 ng/mL, while 
serum B12 concentrations of <200 pg/mL result in deficiency (Gropper et al, 2009). Measurement 
of serum methylmalonic acid and homocysteine are more sensitive in diagnosing B12 deficiency 
as opposed to measuring serum B12. Increased homocysteine concentrations indicate deficiency 
due to decreased B12-depdendent enzyme activity (Rhode et al., 1995; Gropper et al, 2009).  
 Prevalence of deficiencies after bariatric surgery. Various studies have been conducted 
to determine prevalence of folate and B12 deficiencies after bariatric surgery to establish 
effectiveness of routine supplementation practices. Table 1 summarizes the characteristics, 
designs, treatments, results and conclusions of seven studies that measured folate and/or B12 
deficiency prevalence. Limitations of most of these studies include samples of patient 
populations from a single institution, the majority of subjects being female and of Caucasian 
descent, and measurement of outcomes after three years or less. The studies also used different 
values for defining deficiency. 
          Gasteyger, Suter, Gallard and Giusti (2008) found that at two years post-RYGBP, 80% of 
the 137 subjects required additional intramuscular B12 supplementation, and 45% required 
additional folic acid supplementation, in addition to the standard multivitamin preparation 
prescribed at their institution (Gasteyger, Suter, Gallard & Giusti, 2008). Patient diet analysis 
was not included to determine dietary intake of folate and B12 food sources. The population was 
divided into two groups based on pre-op BMI and Roux limb length, however B12 and folate 
deficiency prevalence and supplementation requirement were not compared between the two 
groups. The Roux limb length impacts the extent of bile mixing with fats and fat-soluble 
vitamins, which therefore influences extent of malabsorption and deficiency in RYGBP patients 
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(Jin et al., 2009). Addressing any impact of Roux limb length on water-soluble vitamin 
absorption could provide significant insight on their absorption after RYGBP, which could 
impact suggested supplementation regimens.  
                A prospective study of 75 RYGBP patients five or more years after surgery found that 
61.8% of their patients were vitamin B12 deficient and 5.5% were folic acid deficient by their last 
follow-up appointment (Dalcanale et al., 2009). Only one-third of the sample reported reliable 
adherence to the recommended supplement regimen, which shows a need to place more 
emphasis on patient education and the importance of supplementation and follow-up compliance 
(Dalcanale et al., 2009). The authors did not specify whether the RYGBP procedure performed 
on these patients included long or short-limb modifications. Including Roux-limb length in their 
analysis would have clarified the extent of malabsorption their patients were expected to 
experience. 
             Coupaye et al. (2008) compared gastric bypass and AGB groups, and found lower 
concentrations of B12 in gastric bypass patients one year after surgery compared to baseline 
measurement. A low increase in prevalence after gastric bypass was reported, in five patients at 
baseline compared to six patients at one year. Prevalence in the AGB group increased from 5% 
of the sample population at baseline to 19% after one year. However, 20 patients began 
intramuscular supplementation before the one-year mark. Folate deficiency in the AGB group 
increased from 5% at baseline to 10% after one year, whereas prevalence in the gastric bypass 
group decreased from 4% at baseline to 0% at one year (Coupaye et al., 2008). Neither the 
specific method of folate and B12 measurement, nor the specific gastric bypass method, were 
reported in the literature, and mid-year assessments were not included in the analysis.  
             Toh et al. (2009) reported an increase in B12 deficiency prevalence from 1% preoperative 
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to 11% one-year post surgery in their RYGBP group, contrasting a decrease in prevalence from 
4% preoperative to 0% at one-year post surgery in their study. Folate deficiency, measured by 
erythrocyte folate, increased from 1% at baseline to 12% at one-year in the RYGBP group, 
versus a decrease from 7% to 0% in the sleeve gastrectomy group (Toh et al., 2009). 
Unfortunately, their sample population experienced a significant loss to follow-up and lack of 
comprehensive biochemistry results for all patients, which decreases generalization of their 
results to the general bariatric patient population. Significance of erythrocyte folate has been 
questioned, because few patients develop megaloblastic anemia (Toh et al., 2009). The study did 
not disclose the Roux limb length.  
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Table 1. Summary of folate and vitamin B12 studies after bariatric surgery. 
Author Design Treatment Results Conclusions 
Aasheim et 
al. (2009) 
n=60  
Group 1: GBP 
(23 women, 8 
men) 
Group 2: 
BPD/DS (19 
women, 10 men) 
Duration: 1y 
post-op 
Type: 
Randomized 
clinical trial  
Daily multivitamin supplement, plus 
Fe sulfate: 100 mg 
Ca carbonate: 100mg 
 Vit D3:10 µg 
Folic acid: 200 µg 
GBP patients received additional B12 
supplement: 1 mg 
B12 concentrations 
remained stable in 
BPD/DS patients, and 
increased in GBP 
patients. 
BPD/DS patients 
may require 
different dietary 
supplements and 
monitoring than 
GBP patients. 
 
Coupaye et 
al. (2008) 
n= 70 
AGB: 3 men, 18 
women 
GBP: 4 men, 45 
women 
Duration: 1y 
Type: 
Prospective 
study of 
nutritional 
parameters 
GBP: Multivitamin containing  
B1: 1.6 mg, Folate: 0.8 mg,  
Vit C: 100mg, Vit A: 4,000 IU,  
Vit E: 15 mg, Vit D3: 500 IU,  
Ca: 125 mg, Fe: 60mg  
B12 1,000 µg injections after deficiency 
observed 
AGB: None  
Prevalence of B12 
deficiency increased in 
AGB patients from 
5% at baseline to 19% 
after 1y, and in GBP 
patients from 10% at 
baseline to 12% after 
1y.  
Folate deficiency in 
AGB increased from 
5% at baseline to 10% 
at 1y, and decreased 
from 4% at baseline to 
0% at 1y in GBP 
patients. 
Prevalence of 
deficiencies 
decreased 1y 
after GBP in 
patients taking 
multivitamin 
supplements.  
B12 deficits 
require specific 
supplementation.  
Dalcanale 
et al. 
(2009) 
n=8 men, 67 
women  
Duration: >5y 
after 
documentation 
of RYGBP 
Type: 
Prospective 
study of 
nutritional 
parameters after 
open RYGBP 
>5y prior to 
study 
Materna, 1 tablet/d: 
Retinol: 5,000 IU 
Cholecalciferol 400 IU 
Vit C: 100 mg 
Folic acid 1 mg 
Tocopherol acetate: 30 IU 
Vit B12: 12 µg 
Ca: 250 mg 
Fe: 60 mg 
Cu: 2 mg 
Zn: 25 mg 
61.8% of patients 
exhibited B12 
deficiency at last 
follow-up. 
5.5% of patients 
experienced folic acid 
deficiency at last 
follow-up. 
33.3% reported 
reliable intake 
of supplement 
regimen.  
Values at two years 
remained stable until 
the end of the follow-
up period, except for 
Priorities should 
include patient 
education, more 
aggressive 
prescription of 
and compliance 
with 
supplements, 
and frequent 
clinical and 
biochemical 
follow up. 
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folic acid and zinc. 
Gehrer, 
Kern, 
Peters, 
Christoffel-
Courtin & 
Peter 
(2009) 
n= 136 total 
sleeve 
gastrectomy: 37 
women, 13 men 
RYGBP: 61 
women, 15 men  
Duration: 
Routine follow 
up until 36 mo 
Type: 
Prospective 
study 
Routine post-op 
prescription:  
Berocca brand 
effervescent tablet 
1/: 
 Vit B1: 15 mg 
Vit B2: 15 mg 
Vit B6: 10 mg 
Vit B12: 0.01 mg 
Vit C: 500 mg 
Folic acid: 0.4 mg 
Ca: 100 mg 
Zn: 10 mg 
B12 deficiency 
treatment: 
Vitarubin brand 
1 ampulla/1ml; 
1,000 µg 
cyanocobalamin 
via injection. 
Folate 
deficiency 
treatment:  
Folvite brand 
1mg/d 
Prevalence of B12 
deficiency increased 
from 3% at baseline to 
18% in SG group, and 
to 58% in RYGBP 
group (P value= 
<0.0001). 
Folate deficiency 
increased from 3% to 
22% in SG group and 
12% in RGYBP group 
(P value=0.11). 
SG leads to 
fewer 
deficiencies in 
first 2y than 
RYGBP. 
General 
multivitamin 
supplements 
alone do not 
prevent specific 
deficiencies. 
Gasteyger, 
Suter, 
Gallard, & 
Guisti 
(2008) 
n= 110 women, 
27 men after 
RYGBP 
Group 1: n=90; 
pre-op BMI of 
<48.0  
RYGBP 
limb:100 cm  
Group 2: n=47 
BMI >48.0 
RYGBP limb: 
150 cm 
Duration: 
minimum 2y 
follow-up at 
clinic 
Type: 
Retrospective 
cohort 
Standardized 
multivitamin 
preparation 
prescribed 
between first 
and sixth 
postoperative 
months: 
Vit A: 800 µg 
Vit B12: 3 µg 
Vit C: 180 mg 
Folic acid: 0.6 
mg 
Vit D: 5µg 
Zn: 8 mg 
Specific 
substitutions: 
Vit B12:  
1 mg/mo 
Fe: 80 mg/d 
Ca: 1000 mg/d 
Vit D: 0.02 mg/d 
Folic acid: 1mg/d 
Zn: 5 mg/d 
80% of RYGBP 
patients required B12 
supplementation at 2y. 
45% of RYGBP 
patients required folic 
acid supplementation.  
Post-operative 
supplementation 
with a 
standardized 
multivitamin 
alone is not 
adequate to 
prevent 
nutritional 
deficiencies after 
RYGBP. 
Toh, 
Zarshenas, 
& 
Jorgensen 
(2009) 
n= 232 pre-op, 
183 post-op at 
1y 
AGB: 12 men, 
35 women  
RYGBP: 44 
men 77 women 
Sleeve 
gastrectomy: 27 
men, 37 women 
Duration: 1y  
Type: 
Retrospective 
cohort  
All patients: liquid, effervescent, or 
chewable multivitamin and mineral 
supplement/d 
RYGBP patients: In addition to 
standard supplement, additional 
calcium citrate 1500 mg  
B12 1000 µg injections every 6 mo  
Fe supplements if deficient  
B12 deficiency 
prevalence increased 
from 1% at baseline to 
11% at 1y in RYGBP 
patients. Prevalence 
decreased from 4% at 
baseline to 0% at 1y in 
SG patients.  
RBC folate deficiency 
increased in RYGBP 
from 1% to 12%, but 
decreased in SG from 
7% to 0%. 
Routine nutrition 
screening, 
recommendation 
of appropriate 
supplements and 
adherence 
monitoring is 
necessary.  
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Vargas-
Ruiz, 
Hernandez-
Rivera, 
Herrera 
(2007) 
n= 25 women, 5 
men after 
RYGBP 
Duration: 
Minimum 2y 
follow-up at 
clinic  
Type: 
Retrospective 
cohort 
Uniformly-prescribed Centrum vitamin 
and mineral supplements: 
Dosage: 1 tablet/d 
Contents:  
Fe: 18 mg 
Folic acid: 400 µg 
Cobalamin: 6 µg 
Isolated B12 deficiency 
increased from 0% at 
baseline to 6.6%, 
10%, 16.6%, and 18% 
at 6-mo, 1y, 2y, and 
3y, respectively. 
Folate deficiency did 
not occur.  
Evidence of B12 
deficiency did not 
appear until year two 
post-op. 
Standard 
multivitamins 
with low 
concentrations 
of B12 are not 
sufficient to 
prevent 
deficiency. 
Sleeve 
gastrectomy 
leads to fewer 
deficiencies in 
first 2y than 
RYGBP. 
          Vargas-Ruiz et al. (2007) performed a retrospective analysis of 30 patients at their 
outpatient clinic who completed a minimum follow-up period of at least two years after RYGBP. 
They noted a progressive increase in B12 deficiency prevalence from 0% prior to surgery to 
3.3%, 6.6%, 16.6% and 18% at six months, one year, two years and three years post-procedure, 
respectively. Overall B12 deficiency prevalence, including cases of combined B12 and iron 
deficiency, was recognized min 27% of patients at year three. Folate deficiency was not observed 
in their sample population. Vitamin B12 deficiency was not evident before patients completed at 
least two years of follow-up appointments (Vargas-Ruiz et al., 2007).  
          Aasheim et al. (2009) performed a randomized control trial in which patients underwent 
either laparoscopic RYGBP or BPD/DS, then underwent follow-up at six weeks, six months, and 
one year after surgery. They reported increased B12 concentrations in the RYGBP group after 
additional supplementation, and stable concentrations in BPD/DS patients, who did not receive 
additional B12 supplementation (Aasheim et al., 2009).   
 Treatment. A clinical trial to determine the most effective therapeutic dose of oral 
crystalline vitamin B12 found that in 102 patients who underwent RYGBP, isolated RYGBP, or 
gastroplasty, whose average serum B12 levels were 90 + 21 pmol/L, that at least 350 µg/d of 
crystalline B12 was required to maintain serum levels at or above the reference range of > 150 
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pmol/L in 95% of the sample population. Homocysteine levels dropped below the cut-off point 
with the 350 µg/d dosage but did not drop further with larger doses (p >0.40); despite being 
statistically insignificant, this result is still relevant because it is important to determine 
appropriate dosage of B12 supplementation for bariatric patients. Continuous therapy was found 
to be necessary, as serum B12 levels declined rapidly over three months post treatment (Rhode et 
al., 1995).  
            Most of the previously cited studies concluded that standard multivitamin 
supplementation was usually insufficient to prevent folate and B12 deficiencies and B12 
supplementation should be patient-specific. Frequent clinical follow-up is necessary (Dalcanale 
et al., 2009; Vargas-Ruiz, Hernandez-Rivera & Herrera, 2007; Gehrer et al., 2009; Aasheim et 
al., 2009; Toh., 2009; Coupaye et al., 2008; Gasteyger et al., 2008).  
Iron Deficiency  
 Pathophysiology. Iron deficiency after gastric bypass arises from several characteristics 
of the procedure. Low red meat tolerance is a common result of bariatric surgery, which results 
in decreased consumption (Ruz et al., 2009). Greatly reduced stomach capacity strictly limits 
hydrochloric acid and protease secretion, which are required to hydrolyze heme iron from 
proteins. Reduction in intestinal absorption surface area after gastric bypass consequently results 
in less iron absorption capacity, as absorption is highest in the duodenum and initial portions of 
the jejunum (Gropper et al., 2009; Ruz et al., 2009). Prolonged deficiency ultimately manifests 
as iron deficiency anemia, which results in skin pallor, fatigue, impaired cognitive performance, 
decreased work productivity, and decreased resistance to infection (Gropper et al., 2009).  
 Prevalence of deficiency and treatment recommendations after bariatric surgery. 
Overall, iron deficiency after VGB and AGB is considered rare, but is a more common result of 
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RYGBP and BPD/DS (Malinowski, 2006 & Shah, Simha & Garg, 2010). Table 2 summarizes 
nine studies of iron deficiency prevalence in patients after bariatric surgery. Many of these 
studies suffered from the same pitfalls of the previously mentioned B12 and folate studies: they 
were studies of a patient population of a single institution, the majority of sample populations 
consisted of premenopausal Caucasian women, measurement of outcomes after three years or 
less, and the retrospective cohort studies did not include dietary intake data in their analyses. Not 
all of the studies used a uniform indicator to define deficiency.  
 Ruz et al. (2007) tested the effectiveness of an “improved” supplement regimen against 
their institution’s standard multivitamin recommendation after RYGBP. Typical dietary intake 
was assessed via a 3-day food record and computer analysis; red meat consumption decreased by 
about half post-op versus pre-op amounts. Anemia prevalence increased from 1.5% prior to 
surgery to 38.8% at 18 months (Ruz et al., 2007). Vitamin C concentration was reduced from 
250 mg/d in the standard group to 100 mg/d in the “improved” group. Analysis did not include 
the effect of this decrease on iron absorption, as simultaneous vitamin C ingestion with non-
heme iron is known to increase absorption (Ruz et al., 2007; Gropper et al., 2009). These authors 
found that iron absorption from both a standard diet and a typical dose of ferrous iron ascorbate 
significantly decreased after six months of RYGBP, and an average supplemental iron intake of 
approximately 20 mg/d was largely insufficient in preventing deficiency. Improved highly 
available iron formulations or periodic parenteral infusions are likely necessary to prevent 
deficiency after RYGBP (Ruz et al., 2007).  
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Table 2. Summary of iron deficiency studies. 
Author Design Supplementation Results Conclusion 
Ruz et al. 
(2007) 
n = 67 menstruating 
women after 
RYGBP 
n completed = 51 
Duration: 18 mo 
Group A: Standard 
vitamin and mineral 
supplementation 
Group B: 
“Improved” vitamin 
and mineral 
supplementation 
Type: Experimental 
trial 
Standard: 
Fe: 0 mg 
Ca: 640 mg 
Zn: 7.5 mg 
Cu: 1000 µg 
Se: 15 µg 
Vit C: 250 mg 
Vit E: 200 mg 
Folic acid:  
0 mg 
Vit A: 0 µg 
Vit D: 250 IU 
Improved: 
Fe: 18 mg 
Ca: 1000 mg 
Zn: 15 mg 
Cu: 900 µg 
Se: 55 µg 
Vit C: 100 mg 
Vit E: 200 mg 
Folic acid: 
400 mg 
Vit A: 200 µg 
Vit D: 800 IU 
Differences in 
Fe absorption in 
A and B were 
not significant at 
6, 12 and 18 mo. 
Prevalence of 
anemia 
increased from 
1.5% at baseline 
to 38.8% at 18 
mo 
Prevalence of 
Fe-deficiency 
anemia at 18 
mo: 23.9% 
Average 
supplemental Fe 
intake of ~20 
mg/day is 
insufficient to 
prevent Fe 
deficiency after 
RYGBP. 
Coupaye et 
al. (2008) 
n= 70 
AGB: 3 men, 18 
women 
GBP: 4 men, 45 
women 
Duration: 1y 
Type: Prospective 
study of nutritional 
parameters 
GBP: Multivitamin containing B1: 
1.6 mg, Folate: 0.8 mg, Vit C: 
100mg, Vit A: 4,000 IU, Vit E: 15 
mg, Vit D3: 500 IU, Ca: 125 mg, Fe: 
60mg  
B12 1,000 µg injections after 
deficiency observed 
AGB: None  
Fe deficiency 
anemia 
increased from 
4% at baseline 
to 10% after 1y 
in GBP 
Fe deficiency 
anemia 
prevalence did 
not change from 
baseline to 1y 
after AGB 
(10%). 
Overall 
prevalence 
considered low.  
Prevalence of 
deficiencies 
decreased 1y after 
GBP in patients 
taking 
multivitamin 
supplements.  
Assessment of 
transferrin 
saturation is 
required to 
evaluate risk of Fe 
deficiency in 
obese patients. 
Dalcanale et 
al. (2009) 
n=8 men, 67 women  
Duration: >5y after 
documentation of 
RYGBP 
Type: Prospective 
study of nutritional 
parameters after 
open RYGBP >5y 
prior to study 
Materna, 1 tablet/d: 
Retinol: 5,000 IU 
Cholecalciferol: 400 IU 
Vit C: 100 mg 
Folic acid 1 mg 
Tocopherol acetate: 30 IU 
Vit B12: 12 µg 
Ca: 250 mg 
Fe: 60 mg 
Cu: 2 mg 
Zn: 25 mg 
Deficiencies in 
Hgb (50.8%), Fe 
(29.8%), and 
ferritin (36.0%) 
were evident at 
last follow up. 
33.3% reported 
reliable intake 
of supplement 
regimen. 
Values at two 
years remained 
stable until the 
Priorities should 
include patient 
education, more 
aggressive 
prescription of and 
compliance with 
supplements, and 
frequent clinical 
and biochemical 
follow up. 
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end of the 
follow-up 
period, except 
for folic acid 
and zinc. 
Gehrer, 
Kern, 
Peters, 
Christoffel-
Courtin & 
Peter (2009) 
 
n= 136 total 
sleeve gastrectomy: 
37 women, 13 men 
RYGBP: 61 women, 
15 men  
Duration: Routine 
follow up until 36 
mo 
Type: Prospective 
study 
Routine post-
op 
prescription:  
Berocca 
brand 
effervescent 
tablet 1/d: 
 Vit B1: 15 
mg 
Vit B2: 15 mg 
Vit B6: 10 mg 
Vit B12: 0.01 
mg 
Vit C: 500 
mg 
Folic acid: 
0.4 mg 
Ca: 100 mg 
Zn: 10 mg 
Treatment of:  
Fe deficiency: 100 
mg iron II glycine 
sulphate 1/d 
or 300-900 mg iron 
III hydroxide 
saccharose 1-2/yr 
Prevalence in Fe 
deficiency 
increased from 
3% post-op to 
18% after sleeve 
gastrectomy and 
28% after 
RYGBP at year 
3 (P value: NS).  
Sleeve 
gastrectomy leads 
to fewer 
deficiencies in 
first 2y than 
RYGBP. 
General 
multivitamin 
supplements alone 
do not prevent 
specific 
deficiencies 
Hakeam, 
O’Regan, 
Salem, 
Bamerhriz, 
& Eldali 
(2009) 
n= 31 men and 30 
women after sleeve 
gastrectomy 
Duration: 1y 
Type: Prospective 
cohort 
ADEKs brand Fe-free multivitamin: 
folic acid: 0.2 mg 
cyanocobalamin: 12 mcg 
Fe deficiency 
increased from 
0% to 3% after 
6-mo and 12-mo 
post-op (Two 
females and one 
male). 
Impact of sleeve 
gastrectomy on Fe 
indices was 
negligible. 
Fe 
supplementation is 
likely unnecessary 
in non-anemic 
patients.  
Gasteyger, 
Suter, 
Gallard, & 
Guisti 
(2008) 
n= 110 women, 27 
men after RYGBP 
Group 1: n=90; 
pre-op BMI of 
<48.0  
RYGBP limb:100 
cm  
Group 2: n=47 
BMI >48.0 
RYGBP limb: 150 
cm 
Duration: minimum 
2y follow-up at 
clinic 
Type: Retrospective 
Standardized 
multivitamin 
preparation 
prescribed 
between first 
and sixth 
postoperative 
months: 
Vit A: 800 µg 
Vit B12: 3 µg 
Vit C: 180 mg 
Folic acid: 0.6 
mg 
Vit D: 5µg 
Specific 
substitutions: 
Vit B12:  
1 mg/mo 
Fe: 80 mg/d 
Ca: 1000 mg/d 
Vit D: 0.02 mg/d 
Folic acid: 1mg/d 
Zn: 5 mg/d 
60% of patients 
were prescribed 
additional Fe 
supplementation 
at 24 months 
due to Fe 
deficiency. 
Post-operative 
supplementation 
with a 
standardized 
multivitamin alone 
is not adequate to 
prevent nutritional 
deficiencies after 
RYGBP. 
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cohort Zn: 8 mg 
Toh, 
Zarshenas, 
& Jorgensen 
(2009) 
n= 232 pre-op, 183 
post-op at 1y 
AGB: 12 men, 35 
women  
RYGBP: 44 men 77 
women 
Sleeve gastrectomy: 
27 men, 37 women 
Duration: 1y  
Type: Retrospective 
cohort 
All patients: liquid, effervescent, or 
chewable multivitamin and mineral 
supplement/d 
RYGBP patients: In addition to 
standard supplement, additional 
calcium citrate 1500 mg  
B12 1000 µg injections every 6 mo Fe 
supplements if deficient  
Prevalence in Fe 
deficiency 
increased from 
2% pre-op to 
21% 1y post-op 
in RYGBP. 
Prevalence in Fe 
deficiency at 
pre-op and 1y 
post-op 
remained at 0% 
in SG patients. 
Routine nutrition 
screening, 
recommendation 
of appropriate 
supplements and 
adherence 
monitoring is 
necessary.  
Vargas-
Ruiz, 
Hernandez-
Rivera & 
Herrera 
(2007) 
n= 25 women, 5 
men after RYGBP 
Duration: minimum 
2y follow-up at 
clinic  
Type: Retrospective 
cohort 
Uniformly-prescribed Centrum 
vitamin and mineral supplements: 
Dosage: 1 tablet/day 
Contents:  
Fe: 18 mg 
Folic acid: 400 µg 
Cobalamin: 6 µg 
Prevalence of Fe 
deficiency 
increased from 
16.6% at 
baseline to 
23.3% at 2y 
Five patients 
diagnosed with 
isolated Fe 
deficiency 
remained 
deficient after 
2y.  
Routine practice 
of vitamin 
supplementation is 
not sufficient in 
preventing Fe 
deficiency. 
Varma et al. 
(2008) 
n= 2 AGB, 23 
RYGBP, 17 
BPD/DS  
Duration: Charts 
from May 2004 – 
June 2007 
Type: Retrospective 
cohort 
Oral therapy: ferrous sulfate 325 mg 
(elemental Fe: 65 mg) 3-4/d 
or ferrous fumarate 324 mg 
(elemental iron 106 mg) 2/d 
Parenteral Fe sucrose complex 
(Venofer, 20mg elemental Fe/ml) 
The number of 
anemia-related 
hospitalizations 
and additional 
therapy was 
greater for 
patients who 
underwent 
BPD/DS.   
Incidence after 
AGB was very 
low (4.76%). 
The median 
interval between 
surgery and 
parenteral Fe 
replacement was 
42.5 months.  
Patients who do 
not respond to oral 
Fe therapy should 
be referred early 
for parental Fe.  
Fe monitoring 
should continue 
indefinitely after 
surgery, especially 
in premenopausal 
women. 
 Retrospective and prospective cohort studies on iron deficiency largely concluded that 
routine iron and multivitamin supplementation are inadequate to prevent deficiency after 
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RYGBP, and life-long supplementation, frequent clinical follow-up and adherence to 
supplementation are necessary to prevent deficiency (Vargas-Ruiz, Hernandez-Rivera & Herrera, 
2007; Gasteyger, Suter, Gallard, & Guisti, 2008; Toh, Zarshenas, & Jorgensen, 2009; Dalcanale 
et al., 2009; Gehrer, Kern, Peters, Christoffel-Courtin & Peter, 2009; Varma et al., 2008). 
             Vargas-Ruiz et al. (2007) found an increase in prevalence from 16.6% before RYGBP to 
23.3% at year two (Vargas-Ruiz et al., 2007). Neither diet assessment, nor vitamin C intake with 
the supplement, were included in the analysis, nor were other study limitations included in the 
discussion. Gasteyger et al. (2008) noted that in their sample population, iron supplementation 
was second to vitamin B12 in frequency (60%) by year two (Gasteyger et al., 2008). As seen with 
the previous study, dietary intake was not included in the analysis. Toh et al. (2009) found that 
iron deficiency increased from 2% in their RYGBP group to 21% at one year post surgery. Mean 
ferritin levels dropped significantly in the SG group at one year post surgery, but deficiency 
never occurred. As previously mentioned in the folate and B12 analysis of this paper, the 
significant loss to follow up and lack of biochemistry labs available hindered their attempt at a 
more comprehensive analysis of their population (Toh et al., 2009).  
               Varma et al. (2008) studied bariatric patients who received parenteral iron replacement 
therapy after failure of oral supplementation, and found that hospitalization due to anemia and 
additional iron replacement after the first treatment were more likely to occur after BPD/DS than 
RYGBP, and incidence after AGB was very low, at 4.76%. The median interval period between 
bariatric surgery and date of first parenteral iron replacement therapy was 42.5 months. 
Premenopausal women experienced a much shorter average interval time than men and 
postmenopausal women. They also emphasized the need for lifelong follow up and early referral 
for parenteral iron replacement therapy if patients fail to respond to oral supplementation (Varma 
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et al., 2008).  
 In their prospective cohort, Coupaye et al. (2009) noted an increase in iron deficiency 
from 4% at baseline to 10% after one year of undergoing gastric bypass. The number of reported 
cases did not change in the AGB group, but overall prevalence of deficiency after both 
procedures was considered low. Very few patients took additional oral supplements at year one.   
(Coupaye et al., 2009). The low prevalence may have been due to a routine supplementation 
practice that contained higher concentrations of iron (60 mg/d) than other typical 
supplementation regimens. However, the specific gastric bypass procedure was not reported in 
their study.  
             Dalcanale et al. (2009) reported deficiencies after RYGBP of 50.8%, 29.8% and 36.0% 
in hemoglobin, iron and ferritin, respectively, and massive weight loss, frequent vomiting, 
dumping syndrome, and women of reproductive age were observed as high-risk for developing 
anemia. As noted previously, only about one-third of patients reported reliable intake of 
recommended supplementation at year one (Dalcanale et al., 2009). Gehrer et al. (2010) studied 
SG and RYGBP and observed an increase in iron deficiency prevalence from 3% post surgery to 
18% after SG and 28% after RYGBP at 36 months. Patients were regularly consulted by a 
dietitian to assess diet quality, but food records were not taken and thus not analyzed (Gehrer et 
al., 2010). A unique feature of this study was the extent of the study length, at three years.  
             Hakeam, O’Regan, Salem, Bamerhriz, and Eldali (2009) ran a prospective cohort of 
sleeve gastrectomy on iron indices. They noted a very low increase in prevalence in iron 
deficiency at one year post surgery, and concluded that supplementation is likely unnecessary in 
non-anemic patients undergoing the sleeve gastrectomy procedure. However, the patient 
population was primarily Arab, and management of B12 deficiency was not consistently managed 
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in the study, which may decrease generalizability to other patient populations and may have 
skewed the results (Hakeam, O’Regan, Salem, Bamerhriz, & Eldali, 2009). 
Vitamin D and Calcium Deficiency 
 Pathophysiology. Both vitamin D and calcium are well-known for their role in building 
strong bones. Vitamin D is usually obtained through the diet, supplementation, or sunlight 
exposure. With the help of bile, Vitamin D3 is absorbed most rapidly in the duodenum, but the 
largest amount is absorbed in the distal small intestine (Gropper et al., 2009). Prevalence of 
vitamin D deficiency prior to bariatric surgery has been reported at rates of 60% to 80% (Toh et 
al., 2009). Superobese patients usually must undergo the RYGBP procedure with a longer Roux 
limb length, which increases malabsorption of vitamin D and other fat-soluble vitamins due to 
poor mixing of bile salts that are required for its proper absorption (Jin et al., 2009).  
           Calcium is primarily absorbed in the duodenum and proximal jejunum, which are 
typically bypassed after RYGBP, which results in decreased absorption (Johnson et al., 2006). 
Calcium absorption is vitamin D dependent and is involved in parathyroid hormone (PTH) 
homeostasis, which regulates blood calcium and bone turnover (Gropper et al., 2009).  
 Diagnosis of deficiency. Assessment of vitamin D status involves measuring 25-OH D3, 
which should be maintained >30 ng/mL (Gropper et al., 2009). Serum calcium concentrations 
normally range from approximately 8.5 to 10.5 mg/dL in adults. Serum ionized calcium can 
reflect alterations in calcium metabolism. Bone density is typically assessed through imaging 
such as dual-energy X-ray absorptiometry (DEXA) (Gropper et al., 2009).  
 Consequences of deficiency. The major adverse effect of chronic vitamin D and calcium 
depletions in morbidly obese patients undergoing RYGBP is metabolic bone disease, which 
manifests as osteopenia, osteoporosis, and ultimately osteomalacia (Johnson et al., 2006). 
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Metabolic bone disease results from secondary hyperparathyroidism (HPT). An inverse 
relationship exists between calcium and blood pressure, and is also thought to decrease colorectal 
cancer risk through its ability to bind carcinogenic bile acids and free fatty acids. (Gropper et al., 
2009). Emerging research in vitamin D suggests that it significantly impacts the cardiovascular, 
neuromuscular and immune systems, and participates in cell proliferation, differentiation, and 
apoptosis (Carlin, Rao, Yager, Parikh & Kapke, 2008). 
 Prevalence of deficiency after bariatric surgery. Table 3 summarizes eight vitamin D and 
calcium studies. Carlin, Rao, Yager, Parikh and Kapke (2009) found that vitamin D deficiency 
prevalence decreased significantly in patients who received weekly pharmacologic doses of 
50,000 IU/week in addition to the standard 800 IU/d versus the control group, who received only 
the standard supplementation (Carlin et al., 2009). However, secondary HPT persisted in the 
group receiving the pharmacological dosage. Therefore, additional factors might contribute to 
persistent HPT after RYGBP, such as calcium malabsorption. Hip bone mineral density (BMD) 
decreased by one-third in the supplemented group as opposed to the control group (Carlin et al., 
2009). Aasheim et al. (2009) observed that BPD/DS might be associated with higher risk of 
vitamin D deficiency than RYGBP (Aasheim et al., 2009). Toh et al. (2009) noted a decrease in 
deficiency from more than half prior to surgery to 30% after RYGBP and 42% after GS at one 
year, however they were unable to account for seasonal variations in preoperative 25-OHD 
levels, and as previously mentioned the study suffered from a large loss to follow up (Toh et al., 
2009). The impact of Roux limb length was not disclosed in their study; including Roux limb 
length in the analysis would provide additional insight into how it impacted absorption in their 
sample population. Coupaye et al. (2009) found that better supplement regimen compliance 
resulted in greater reductions in deficiency (Coupaye et al., 2009). As previously mentioned, the 
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authors did not disclose the specific gastric bypass procedure, which would have provided 
additional insight into the expected extent of vitamin D malabsorption and how supplementation 
impacted expected deficiency. 
            Gasteyger et al. (2008) observed that 60% of patients required vitamin D and calcium 
supplementation at two years after gastric bypass, and deficiency risk was higher in patients with 
a BMI >48.0 who required a longer Roux limb. The proportion of patients who required calcium 
and vitamin D3 supplementation post-op was significantly higher in group 2, who required a 
longer Roux limb, than in group 1, who required a shorter Roux limb (74% compared with 52% 
respectively; P value=0.02) (Gasteyger et al., 2008). 
           Johnson, Maher, DeMaria, Downs, Wolfe, & Kellum (2006), in their longitudinal study, 
observed a similar result to Gastegeyer et al. (2009), in which patients with a Roux limb >100 
cm had a significantly lower serum 25-OHD level than patients with a Roux limb <100 cm, and 
progressive increase in prevalence the longer patients were followed up after the procedure. 
Average post-op follow-up was longer in the >100 cm group (5.7 + 2.5 years) when compared to 
the <100 cm group (3.1 + 3.6 years) (Johnson et al., 2006). This difference in the extent of 
follow-up may have skewed the results, as equivalent extent of follow-up in both groups may or 
may not have revealed increased prevalence of deficiency in the shorter Roux limb group. 
        A study by Flores et al. (2010) found vitamin D insufficiency and deficiency in 80% of their 
sample population, which significantly decreased after one year. They were able to observe 
seasonal variations in serum vitamin D concentrations, however their results may have been 
affected by the unavailability of calcium citrate at their facility in Spain (Flores et al., 2010).  
         Jin et al. (2009) identified several independent risk factors for developing vitamin D 
deficiency after RYGBP: being of African-American descent, having a pre-operation serum 25-
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OHD level of <16 ng/mL, and having a Roux limb of ~160 cm. Prevalence of vitamin D 
deficiency in their study increased from 41% prior to surgery to 42% after one year. By year one, 
71% patients who were deficient prior to surgery remained deficient, despite oral vitamin D and 
calcium supplementation (Jin et al., 2009). The authors did appear to monitor supplement 
adherence monitoring in their patient sample. Lack of patient accountability weakens their 
conclusion, as poor adherence would increase risk of deficiency while causing their independent 
risk factors to be viewed as the main predictors of vitamin D deficiency.  
 Treatment. No consensus currently exists regarding the amount of supplemental vitamin 
D required to optimize nutritional status and to prevent potential adverse effects of deficiency in 
patients after RYGBP (Carlin et al., 2009). A recent randomized control trial found that calcium 
citrate was superior to calcium carbonate in bioavailability and ability to reduce PTH after 
RYGBP. Calcium carbonate absorption is dependent on gastric acid secretion, whereas calcium 
citrate is partially soluble in water, allowing for increased bioavailability (Tondapu et al. 2009). 
Vitamin D doses as high as 50,000 IU/week have been suggested to treat deficiency. Serum 25-
OHD should be checked every six to twelve months to detect deficiency early (Carlin et al., 
2009). At most institutions, the common daily recommended amount of vitamin D is 400 I.U. to 
800 I.U. However, this regimen is based on requirements of non-obese patients and does not 
account for malabsorption of vitamin D after gastric bypass surgery (Jin et al., 2009).  
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Table 3. Summary of vitamin D and calcium studies. 
Author Design Supplementation Results Conclusion 
Aasheim 
et al. 
(2009) 
n=60  
Group 1: GBP (23 
women, 8 men) 
Group 2: BPD/DS (19 
women, 10 men) 
Duration: 1y post-op 
Type: Randomized 
clinical trial  
Daily multivitamin 
supplement, plus 
Fe sulfate: 100 mg 
Ca carbonate: 100mg 
 Vit D3:10 µg 
Folic acid: 200 µg 
GBP patients received 
additional B12 supplement: 1 
mg 
25-OHD concentrations 
increased in RYGBP 
patients  (P < 0.001) but 
tended to decrease 
among BPD/DS 
patients (P = 0.059). 
PTH and ionized 
calcium concentrations 
did not change 
significantly after 
surgery.  
1,25 dihydroxyvitamin 
D concentrations 
increased during the 1y 
follow-up (P <0.001). 
BPD/DS may be 
associated with 
greater risk of vitamin 
D deficiency the first 
year after surgery.  
Carlin, 
Rao, 
Yager, 
Parikh, & 
Kapke 
(2009) 
n=60 morbidly obese, 
Vit D depleted 
women  
Duration: 1 yr after 
RYGBP  
Type: Randomized 
clinical trial 
Both groups:  
Vitamin D: 800 IU/d 
Calcium: 1500mg/d 
Group 1: Additional 50,000 
IU vitamin D/weekly 
Group 2: No additional 
vitamin D supplementation 
Group 1 experienced 
significantly lower 
vitamin D depletion at 
3, 6 and 12 mo post 
surgery.  
The magnitude of 
decline in hip BMD 
was 33% lower in 
group 1.  
HTN resolution was 
75% in group 1 vs. 32% 
in group 2.  
Bone turnover 
elevations existed in 
both groups. 
A weekly 
pharmacologic dose 
of 50,000 IU of 
vitamin D appears 
safe and effective in 
improving depletion 
after RYGBP in 
morbidly obese 
patients. 
Secondary HPT 
persisted in group 1 
despite increased 
serum 25-OHD 
levels, likely due to 
calcium 
malabsorption. 
Coupaye 
et al. 
(2008) 
n= 70 
AGB: 3 men, 18 
women 
GBP: 4 men, 45 
women 
Duration: 1y 
Type: Prospective 
study of nutritional 
parameters 
GBP: Multivitamin containing 
B1: 1.6 mg, Folate: 0.8 mg, 
Vit C: 100mg, Vit A: 4,000 
IU, Vit E: 15 mg, Vit D3: 500 
IU, Ca: 125 mg, Fe: 60mg  
B12 1,000 µg injections after 
deficiency observed 
AGB: None  
25OH-D deficiency 
decreased from 14% at 
baseline to 5% at 1y 
after AGB, and from 
16% at baseline to 10% 
at 1y after gastric 
bypass.  
Vitamin D was 
significantly higher in 
patients with a good 
index of medication 
adherence.  
Prevalence of 
deficiencies 
decreased 1y after 
GBP in patients 
taking multivitamin 
supplements.  
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Flores et 
al. (2010) 
n=222 
after RYGBP 
Duration: 1y 
Type: Prospective 
cohort 
 
Elemental calcium carbonate: 
1200 mg/d 
and vitamin D3: 800 IU 
as combined chewable tablets 
Dietetic reinforcement with 
calcium-rich foods. 
Baseline insufficiency 
and deficiency of 
vitamin D observed in 
80% of patients.  
25OH-D significantly 
increased and PTH 
decreased at 1y 
compared to preop 
values.  
Calcium and vitamin 
D supplementation 
should be universal 
and not dependent on 
baseline levels.  
Supplementation 
should be 
individualized 
according to 
deficiency. 
Johnson, 
Maher, 
DeMaria, 
Downs, 
Wolfe, & 
Kellum 
(2006) 
n=243 
Roux >100 cm: 41 
Roux <100 cm: 202 
Duration: >5y 
Type: Prospective 
longitudinal cohort 
 
NA Roux >100 cm had a 
significantly lower 
serum D level when 
compared to those with 
Roux <100 cm 
88.9% had an elevated 
PTH, and 42.1% of 
those with normal 
vitamin D levels had 
elevated PTH. 
Vitamin D levels 
progressively decreased 
and PTH levels 
increased the longer 
patients were followed 
up after surgery. 
Beyond 5 years of 
follow up, few patients 
had levels > 30 ng/mL. 
Further follow up 
studies are necessary 
to determine whether 
routine 
supplementation of 
vitamin D and 
calcium will prevent 
secondary PTH in 
RYGBP patients 
Gasteyger, 
Suter, 
Gallard, & 
Guisti 
(2008) 
n= 110 women, 27 
men after RYGBP 
Group 1: n=90; 
pre-op BMI of <48.0  
RYGBP limb:100 cm  
Group 2: n=47 
BMI >48.0 
RYGBP limb: 150 cm 
Duration: minimum 
2y follow-up at clinic 
Type: Retrospective 
cohort 
Standardized 
multivitamin 
preparation 
prescribed 
between first 
and sixth 
postoperative 
months: 
Vit A: 800 
µg 
Vit B12: 3 µg 
Vit C: 180 
mg 
Folic acid: 
0.6 mg 
Vit D: 5µg 
Zn: 8 mg 
Specific 
substitutions: 
Vit B12:  
1 mg/mo 
Fe: 80 mg/d 
Ca: 1000 
mg/d 
Vit D: 0.02 
mg/d 
Folic acid: 
1mg/d 
Zn: 5 mg/d 
Calcium + vitamin D3 
supplementation was 
required in 60% of 
patients by 2y.  
In group 2, 74% of 
patients required 
calcium and D3 
supplementation 
compared to 52% in 
group 1.  
Prevalence of vitamin 
D and calcium 
deficiency increases 
significantly with the 
length of the RYGBP 
limb. 
Post-operative 
supplementation with 
a standardized 
multivitamin alone is 
not adequate to 
prevent nutritional 
deficiencies after 
RYGBP. 
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Jin et al. 
(2009) 
n=145 
after RYGBP 
Duration: 1y 
Type: Retrospective 
cohort 
Starting dose of elemental 
calcium: 1000mg/d 
Vitamin D: 400-800 IU/d 
41% of patients had 
vitamin D deficiency at 
baseline, then increased 
slightly to 42%. 
Patients with preop 
vitamin D levels <16 
ng/mL are almost 7 
times more likely to 
continue their 
deficiency post 
operative when 
compared to patients 
with levels >16 ng/mL. 
 
Clinicians should 
aggressively treat 
patients with vitamin 
D deficiency prior to 
undergoing RYGBP 
to ensure a more 
optimal long-term 
outcome. 
Preoperative D levels 
<16 ng/mL, 
African-American 
race, and Roux limb 
~160 cm were 
recognized as 
independent risk 
factors for 
postoperative 
deficiency. (P values= 
0.01, 0.006 and 0.03, 
respectively) 
Toh, 
Zarshenas, 
& 
Jorgensen 
(2009) 
n= 232 pre-op, 183 
post-op at 1y 
AGB: 12 men, 35 
women  
RYGBP: 44 men 77 
women 
Sleeve gastrectomy: 
27 men, 37 women 
Duration: 1y  
Type: Retrospective 
cohort 
All patients: liquid, 
effervescent, or chewable 
multivitamin and mineral 
supplement/d 
RYGBP patients: In addition 
to standard supplement, 
additional calcium citrate 
1500 mg  
B12 1000 µg injections every 6 
mo Fe supplements if 
deficient  
More than half of 
patients presented 
vitamin D deficiency 
prior to surgery.  
Prevalence decreased 
from 46% prior to 
surgery in RYGBP 
patients to 30% after 
1y, and from 92% prior 
to surgery in SG 
patients to 43% after 
1y. 
Vitamin D deficiency 
is common among 
morbidly obese 
patients seeking 
bariatric surgery.  
Routine nutrition 
screening, 
recommendation of 
appropriate 
supplements and 
adherence monitoring 
is necessary.  
 
                General Prevention and Treatment Recommendations, and Future Research 
Prevention and Treatment 
 Many of the studies mentioned in this review noted poor patient compliance to 
recommended supplementation regimens, and suggested frequent, life-long follow-up to detect 
deficiencies early. Patients have many reasons for not complying with supplemental 
prescriptions. Oral iron supplements are known to cause digestive problems, which discourages 
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regular intake (Coupaye et al., 2009). Gesteyger et al. (2008) estimated that two years post 
RYGBP, patients would have to spend an average of $35 USD monthly for nutritional 
supplements, an amount high enough to impair compliance in a significant proportion of patients 
in countries in which health insurance does not cover these costs (Gesteyger et al., 2008).  
            Other known predictors of poor adherence include depression, treatment of asymptomatic 
disease, complexity of taking many supplements, and lack of belief in the benefit of treatment 
(Aasheim et al., 2009).  
            Over-the-counter multivitamin and mineral supplements do not provide adequate 
concentrations of certain micronutrients, such as B12, iron, or fat-soluble vitamins, and patients 
will require life-long prophylactic supplementation to maintain optimal nutrient status (Shankar, 
Boylan, & Sriram, 2010). Development of a single “multi-pill” or injection containing 
appropriate doses of vitamin B12, iron, calcium, vitamin D3, and folic acid would facilitate 
compliance and reduce the patient’s cost burden (Gasteyger, 2008). In order to get the most out 
of their supplementation regimen, patients should be made aware of foods that can enhance or 
inhibit absorption of micronutrients, such as iron being inhibited by tea consumption but 
enhanced by vitamin C consumption (Coupaye et al., 2009). A possible learning tool to use in 
bariatric surgery counseling for patients is a pyramid in the likeness of the USDA Food Guide 
Pyramid, which includes reminders for supplements at its base (Moize, Pi-Sunyer, Mochari & 
Vidal, 2010). Figure 3 below depicts the suggested pyramid guide for gastric bypass patients.  
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Figure 3. Nutritional pyramid guide for gastric bypass patients (Moize et al., 2010). 
 
Future Research Needs 
 As previously noted, most of the studies included in this review were limited by short 
intervals between undergoing bariatric surgery and last follow-up, the longest was up to five 
years post-surgery (Dalcanale et al., 2009). Further study of long-term health outcomes after 
bariatric surgery is especially important in regards to deficiencies such as vitamin D and calcium, 
which can lead to severe bone loss and greater risk of fracture, and iron, which can suppress the 
immune system and increase susceptibility to life-threatening infections. These long-term studies 
would ideally be prospective in nature in order to establish time-order relationships and capture 
and analyze diet, and in the case of vitamin D, sun exposure. Ideally patient populations would 
be more diverse, as the studies cited in this paper had sample populations who were 
overwhelmingly Causasian women of reproductive age, which decreases generalizability toward 
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other ethnicities, ages, and men. Patient education and motivation should also be explored in 
order to determine the best methods of increasing and encouraging supplementation compliance.  
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